Estrogens and psychiatric disorders in women: A review;Estrogeny a psychické poruchy u žen

Psychiatrie

Volumn 7, Issue 3, 2003, Pages 178-183

  Stárka, Luboslav ^a   Bičiková, Marie ^a   Hill, Martin ^a   Kančeva, Ludmila ^a   Hájek, Tomáš ^a  

^a INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

Author keywords

Affective disorders; Catamenial epilepsy; Estrogens; Menarche; Menopause; Perimenopause; Premenstrual syndrome

Indexed keywords

ANTIDEPRESSANT AGENT; ESTROGEN; SEX HORMONE;

ADJUVANT THERAPY; CLINICAL FEATURE; CORRELATION ANALYSIS; ESTROGEN ACTIVITY; FEMALE; HOMEOSTASIS; HORMONAL REGULATION; HUMAN; LIFE CYCLE; MENARCHE; MENOPAUSE; MENSTRUAL CYCLE; MENTAL DISEASE; MOOD DISORDER; NEUROPATHOLOGY; PREMENSTRUAL SYNDROME; PSYCHOSIS; PUERPERAL PSYCHOSIS; REVIEW; SEXUAL BEHAVIOR;

EID: 0141814682     PISSN: 12117579     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Ahokas A, Kaukoranta J, Aito M. Effect of estradiol on postpartum depression. Psychopharmacology 1999;146:108-110.
2. Angold A, Costello EJ, Worthman CJ. Puberty and depression: the roles of age, pubertal status and pubertal timing. Psychol Med 1998;28:51-61.
3. Behl Ch. Oestrogen as a neuroprotective hormone. Nature Rev Neuroscience 2002a;3:433-442.
4. Behl C. Sex hormones, neuroprotection and cognition. Prog Brain Res 2002b;138:135-142.
5. Behl Ch, Manthey D. Neuroprotective activities of estrogen: An update. J Neurocytology 2000;29:351-359.
6. Bičíková M, Dibbelt L, Hill M, Hampl R, Stárka L. Allopregnanolone in women with premenstrual syndrome. Horm Metab Res 1998;30:227-230.
7. Bičiková, M, Putz Z, Hill M, Hampl R, Dibbelt L, Tallová J, Stárka L. Serum levels of neurosteroid allopregnanolone in patients with premenstrual syndrome and patients after thyroidectomy. Endocr Regul 1998;32:87-92.
8. Bičíková M, Hill M, Havliková H, Cibula D. Catamenial epilepsy and neuroactive steroids. In Book of Abstracts. 2nd International Symposium on Progestins, Progesterone Receptor Modulators and Progesterone Antagonists. Siena, Italy, 2002;50.
9. Bloch M, Schmidt PJ, Danceau M et al. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 2000;157:924-930.
10. Brace M, MacCauley. Oestrogens and psychological well-being. Ann Med 1977;29:283-290.
11. Brinton BD: Cellular and molecular mechanisms of estrogen regulation of memory function against Alzheimer's disease: Recent insights and remaining challanges. Leaming Memory 2001;8:121-133.
12. Caranza-Lira S, Valentino-Figuerola ML. Estrogen therapy for depression in postmenopausal women. Int J Gynecol Obstet 1999;65:35-38.
13. Cohen RZ, Seeman MV, Gotowiec A, Kopala L. Earlier puberty as a predictor of later onset of schizophrenia in women. Am J Psychiatry 1999;156:1059-1064.
14. Davies A, McIvor RJ, Kumar RC. Impact of childbirth on a series of schizophrenic mothers: a comment on the possible influence of oestrogen on schizophrenia. Schizophr Res 1995;16:25-31.
15. Dickerson LM, Mazyck PJ, Hunter MH. Premenstrual syndrome. Am Fam Physician 2003;67:1743-1752.
16. Dimmock PW, Wyatt KM, Jones PW, O'Brien PM. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet 2000;356:1131-1136.
17. Dorda M, Vlček K, Chodounská H, Vyklický L jr. Neurosteroidy mechanizmus působení a možnosti užití v klinické praxi. Psychiatrie 2001;5(Suppl.3):5-9.
18. Duncko R, Kiss A, Skultetyová I, Rusnak M, Ježová D. Corticotropin-releasing hormone mRNA levels in response to chronic mild stress rise in male but not in female rats while tyrosin hydroxylase mRNA levels decrease in both sexes. Psychoneuroendocrinology 2001;26:77-89.
19. Eriksson E, Hedberg MA, Andersch B, Sundblad C. The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology 1995;12:167-176.
20. Freedman MA. Quality of life and menopause: the role of estrogen. J Womens Health (Larchmt) 2002;11:703-718.
21. Galea LA, Wide JK, Barr AM. Estradiol alleviates depressive-like syndrom symptoms in a novel animal model of post-partum depression. Behav Brain Res 2001;122:1-9.
22. Garcia-Segura LM, Azcoitia I, DonCarlos LL. Neuroprotection by estradiol. Prog Neurobiol 2001;63:29-60.
23. Garlow SJ, Musselman DJ, Nemeroff CB. The neurochemistry of mood disorders: clinical studies In: Charney DS, Nestler EJ, Bunney BS, eds, Neurobiology of Mental Illness. New York: University Oxford Press, 1999:248-364.
24. Genazzani AR, Bernardi F. Estrogen effects on neuroendocrine function: the new challenge of pulsed therapy. Climacteric 2002;5(Suppl 2):50-56.
25. Hafner H, Behrens S, De Vry J, Gattaz WF. An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia. Psychiatry Res 1991;38:125-134.
26. Hafner H, Maurer K, Loffler W, an der Heiden W, Munk-Jorgensen P, Hambrecht M, Riecher-Rossler A. The ABC Schizophrenia Study: a preliminary overview of the results. Soc Psychiatry Psychiatr Epidemiol 1998;33:380-386.
27. Halbreich U. Menstrually related disorders: what we do know, what we only believe that we know, and what we know that we do not know. Crit Rev Neurobiol 1995;9:163-175.
28. Halbreich U. Role of estrogen in postmenopausal depression. Neurolgy 1997;48(Suppl. 7):S16-20.
29. Halbreich U, Kahn L. Role of estrogen in the aetiology and treatment of mood disorders. CNS Drugs 2001;15:797-817.
30. Herzog AG, Klein P, Ransil BJ. Three patterns of catamenial epilepsy. Epilepsia 1997;38:1082-1088.
31. Hurn PD, Macrae IM. Estrogen as neuroprotectant in stroke. J Cerebral Blood Flow Metab 2000;20:631-652.
32. Chabbert-Buffet A, Skinner DC, Caraty A, Bouchard P. Neuroendocrine effects of progesterone. Steroids 2000;65:613-620.
33. Jenkins JA, Williams P, Kramer GL, Davis LL, Petty F. The influence of gender and the estrous cycle on learned helplessness in the rat. Biol Psychol 2001;58:147-158.
34. Klein P, Herzog G. Hormone effects on epilepsy in women. Epilepsia 1998;39:S9-S16.
35. Kulkarni J, Riedel A, De Castella AR, Fitzgerald PB, Rolfe TJ, Taffe J, Burger H. Estrogen - a potential treatment for schizophrenia. Schizophr Res 1-3-2001;48:137-144.
36. Lachowsky M. Estrogen therapy: from women's choice to women's preference. Climacteric. 2002;5(Suppl 2):46-49.
37. Lewinsohn PM, Rohde P, Seeley JR. Major depressive disorder in older adolescents: prevalence, risk factors, and clinical implications. Clin Psychol Rev 1998;18:765-794.
38. Lindamer LA, Buse DC, Lohr JB, Jeste DV. Hormone replacement therapy in postmenopausal women with schizophrenia: positive effect on negative symptoms? Biol Psychiatry 2001;49:47-51.
39. Mattsson LA. Safety and tolerability of pulsed estrogen therapy: key factors for an improved compliance. Climacteric 2002;5(Suppl 2):40-45.
40. Monteleone P, Luisi S, Tonetti A, Bernardi F, Genazzani AD, Luisi M, Petraglia F, Genazzani AR. Allopregnanolone concentrations and premenstrual syndrome. Eur J Endocrinol 2000;142:269-273.
41. Reddy DS, Rogawski MA. Enhanced anticolvunsant activity of ganaxololle after neurosteroid withdrawal in a rat model of catamenial epilepsy. J Pharmacol Exp Ther. 2000;294:909-915.
42. Reddy DS, Kim HY, Rogawski MA. Neurosteroid withdrawal model of premenstrual catamenial epilepsy. Epilepsia 2001;42:337-344.
43. Richardson TA, Robinson RD. Menopause and depression: a review of psychologic function and sex steroid neurobiology during the menopause. Prim Care Update Ob Gyns 2000;7:215-223.
44. Riecher-Rossler A, Hafner H. Schizophrenia and oestrogens-is there an association? Eur Arch Psychiatry Clin Neurosci 1993;242:323-328.
45. Riecher-Rossler A, Hafner H, Stumbaum M, Maurer K, Schmidt R. Can estradiol modulate schizophrenic symptomatology? Schizophr Bull 1994;20:203-214.
46. Robinson GE. Psychotic and mood disorders associated with the perimenopausal period Epidemiology, aetiology and mangement. CNS Drugs 2001;15:175-184.
47. Rubinow DR, Schmidt PJ, Roca CA. Estrogen-serotonin interactions: implications for affective regulation. Biol Psychiatry 1998;44:839-850.
48. Silva I, Mor G, Naftolin F. Estrogen and the aging brain. Maturitas 2001;38:95-101.
49. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 1998;338:209-216.
50. Schmidt PJ, Nieman L, Danceau MA et al. Estrogen replacement in perimenopause-reked depression: a preliminary report. Am J Obstetr Gynecol 2000;183:414-420.
51. Schmidt PJ, Roca CA, Bloch M et al. The perimenopause and affective disorders. Semin Reprod Endocrinol 1997;15:91-100.
52. Soares CN, Alimeida OP, Joffe H et al. Efficiacy of estradiol for the treatment of depressive disorders in perimenopausal women. Arch Gen Psychiatry 2001;58:529-534.
53. Stárka L. Jak je to s riziky hormonálni náhradní terapie (HRT) u postmenopauzálních žen? Diabet Metab Endokrin Výživa 2003;6:30-32.
54. Wiklund I, Karlberg J, Mattson L. Quality of life of menopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo controlled study. Am J Obstetr Gynecol 1993;168:824-830.
55. Wise PM, Dubal DB, Wilson ME, Rau SW, Böttner M. Minireview: Neuroprotective effects of estrogen - new insights into mechanism of action. Endocrinology 2001;142:969-973.
56. Wise PM, Dubal DB, Wilson ME, Rau SW, Liu Y. Estrogens: trophic and protective factors in the adult brain. Front Neuroendocrinol 2001;22:33-66.